Further, there is evidence that HER3, a family member also present in ovarian cancers and associated with increased tumor aggressiveness [144] and poor prognosis [145], plays a critical role in EGFR- and HER2-driven tumors (reviewed in [146]). Here, EGFR is linked to neoplasm.